Levofloxacin injection — CareFirst (Caremark)

Initial criteria

• Patient age ≥ 18 years
• Used for treatment of listed infections caused by susceptible isolates of designated microorganisms
• Intravenous administration is indicated when advantageous to patient (cannot tolerate oral dosage)
• Use only to treat or prevent infections proven or strongly suspected to be caused by susceptible bacteria
• Prolonged therapy beyond 28 days in adults or 14 days in pediatric patients only when benefits outweigh risks